News

A new global study reveals a striking post-pandemic surge in gut-brain disorders like IBS and functional dyspepsia.
Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the Treatment of Moderate to Severe Ulcerative Colitis  GlobeNewswire, Inc.